Does paclitaxel-carboplatin chemotherapy in a dose-dense regimen enhance survival of BRCA-related ovarian cancer patients? [electronic resource]
Producer: 20100304Description: 1501-4 p. digitalISSN:- 1525-1438
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- BRCA1 Protein -- genetics
- Carboplatin -- administration & dosage
- Carcinoma -- drug therapy
- Cell Transformation, Neoplastic -- genetics
- Dose-Response Relationship, Drug
- Female
- Genetic Predisposition to Disease
- Humans
- Middle Aged
- Ovarian Neoplasms -- drug therapy
- Paclitaxel -- administration & dosage
- Retrospective Studies
- Survival Analysis
- Treatment Outcome
No physical items for this record
Publication Type: Evaluation Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.